SCHEMBL24508323

SCHEMBL24508323

O=C1CCN(c2cncc3c(C#CCOC4CCNCC4)cccc23)C(=O)N1

nearest known ligand 0.39

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 13/20 0.39
DDB1 Q16531 12/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30545126 1.00 CRBN (0.39) CRBNDDB1
SCHEMBL30543656 0.86 DDB1 (0.36) CRBNDDB1
SCHEMBL31211812 0.86 DDB1 (0.40) CRBNDDB1
SCHEMBL25338787 0.86 DDB1 (0.36) CRBNDDB1
SCHEMBL25337893 0.86 DDB1 (0.40) CRBNDDB1
SCHEMBL24508322 0.84 DDB1 (0.48) CRBNDDB1
SCHEMBL30545185 0.83 MELK (0.37) CRBNDDB1
SCHEMBL24509261 0.83 MELK (0.37) CRBNDDB1
SCHEMBL23832666 0.83 CRBN (0.37) CRBNDDB1
SCHEMBL30225582 0.83 CRBN (0.37) CRBNDDB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116669722-A Interleukin-1 receptor-related kinase (IRAK) degradants and uses thereof 凯麦拉医疗公司 2023-08-29 CN disclosed
WO-2022125790-A1 IRAK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2022-06-16 WO disclosed